MDT

86.56

+0.83%↑

A

113.95

+1.74%↑

VEEV

175.31

+0.07%↑

HQY

83.18

+1.87%↑

CSBR

5.69

+2.34%↑

MDT

86.56

+0.83%↑

A

113.95

+1.74%↑

VEEV

175.31

+0.07%↑

HQY

83.18

+1.87%↑

CSBR

5.69

+2.34%↑

MDT

86.56

+0.83%↑

A

113.95

+1.74%↑

VEEV

175.31

+0.07%↑

HQY

83.18

+1.87%↑

CSBR

5.69

+2.34%↑

MDT

86.56

+0.83%↑

A

113.95

+1.74%↑

VEEV

175.31

+0.07%↑

HQY

83.18

+1.87%↑

CSBR

5.69

+2.34%↑

MDT

86.56

+0.83%↑

A

113.95

+1.74%↑

VEEV

175.31

+0.07%↑

HQY

83.18

+1.87%↑

CSBR

5.69

+2.34%↑

Search

AmerisourceBergen Corporation

Fermé

SecteurSoins de santé

0

Résumé

Variation du prix de l'action

24h

Actuel

Min

Max

Chiffres clés

By Trading Economics

Revenu

906M

566M

Ventes

2.2B

86B

P/E

Moyenne du Secteur

38.442

57.05

BPA

4.08

Rendement du dividende

0.69

Marge bénéficiaire

0.659

Employés

47,000

EBITDA

858M

1B

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+32.75% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

0.69%

2.52%

Prochains Résultats

6 mai 2026

Date du Prochain Dividende

1 juin 2026

Date du Prochain Détachement de Dividende

15 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-8.4B

62B

Ouverture précédente

0

Clôture précédente

0

Sentiment de l'Actualité

By Acuity

6%

94%

5 / 349 Classement par Healthcare

AmerisourceBergen Corporation Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

30 mars 2026, 23:15 UTC

Principaux Événements d'Actualité

U.K. Shoppers Paid a Little More This Month But Worse May yet Lie Ahead

30 mars 2026, 22:36 UTC

Principaux Événements d'Actualité

Australian Government Rules Out Boots on the Ground in the Middle East

30 mars 2026, 22:13 UTC

Acquisitions, Fusions, Rachats

Sun Life Financial Agrees to Buy Bell Partners for $350 Million

30 mars 2026, 21:00 UTC

Résultats

Aktis Oncology Gets FDA Clearance for Phase 1 Billion Trial of Tumor Treatment

30 mars 2026, 20:15 UTC

Principaux Événements d'Actualité

Fed's Williams: Middle-East Developments Have Added Significant Economic Uncertainty

30 mars 2026, 23:40 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30 mars 2026, 23:40 UTC

Market Talk

Nikkei May Decline on Higher Energy Cost Concerns -- Market Talk

30 mars 2026, 23:36 UTC

Market Talk

Gold Edges Lower Amid Divergent Signals on U.S.-Iran Talks -- Market Talk

30 mars 2026, 23:12 UTC

Market Talk

Alcoa Earnings Outlook Boosted by Market Disruptions -- Market Talk

30 mars 2026, 22:49 UTC

Market Talk

Fed's Williams: Core Inflation Forecast Is Little Changed -- Market Talk

30 mars 2026, 22:44 UTC

Market Talk

Fed's Williams: Risks to Both Sides of Dual Mandate Higher -- Market Talk

30 mars 2026, 22:43 UTC

Market Talk

Fed's Williams Says Focus Is on Inflation Expectations Being Well Anchored -- Market Talk

30 mars 2026, 22:42 UTC

Market Talk

South32 Should Go for Growth, Says New Bull -- Market Talk

30 mars 2026, 22:18 UTC

Market Talk

Paragon Care's Chances of Using Levy to Pass on Higher Costs `Close to Zero' -- Market Talk

30 mars 2026, 22:05 UTC

Market Talk

Northern Star's New Bull Argues Case for Asset Sales -- Market Talk

30 mars 2026, 21:58 UTC

Acquisitions, Fusions, Rachats

Sun Life Financial Agrees to Buy Bell Partners for $350M

30 mars 2026, 21:39 UTC

Acquisitions, Fusions, Rachats

Sun Life Sees 1Q Charge to Net of C$236M From BGO, Crescent Deals

30 mars 2026, 21:38 UTC

Acquisitions, Fusions, Rachats

Sun Life: Completes Remaining Equity Interest Purchases of BGO, Crescent Capital

30 mars 2026, 21:36 UTC

Acquisitions, Fusions, Rachats

Sun Life to Buy Fully Bell Partners for $350M >SLF.T

30 mars 2026, 21:33 UTC

Acquisitions, Fusions, Rachats

Unilever Shareholders Expected to Own Two-Thirds of New Food Entity, Sources Say -- WSJ

30 mars 2026, 21:33 UTC

Acquisitions, Fusions, Rachats

Unilever Nears Deal to Create $60 Billion Food Giant With McCormick -- WSJ

30 mars 2026, 21:33 UTC

Acquisitions, Fusions, Rachats

Deal Could Be Announced As Soon As Tuesday, Sources Say -- WSJ

30 mars 2026, 21:33 UTC

Acquisitions, Fusions, Rachats

Unilever Nears Cash-and-Stock Deal to Combine Food Business With McCormick, Sources Say -- WSJ

30 mars 2026, 21:33 UTC

Acquisitions, Fusions, Rachats

Deal Set to Value Combined Food Business At Around $60B Including Debt, Sources Say -- WSJ

30 mars 2026, 21:25 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30 mars 2026, 21:25 UTC

Market Talk

Warehouse Showing Cost Discipline But Margin Goal at Risk -- Market Talk

30 mars 2026, 21:03 UTC

Acquisitions, Fusions, Rachats

Sun Life: Completes Equity Interest Purchases of BGO and Crescent Cap, Announces Acquisition of Bell Partners, a Multifamily Real Estate Investment Manager

30 mars 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

30 mars 2026, 20:09 UTC

Résultats

This Stock Looks Like a Solid AI Bet -- and Wall Street Hasn't Noticed Yet -- Barrons.com

30 mars 2026, 20:00 UTC

Principaux Événements d'Actualité

Fed's Williams: Middle-East Conflict 'Will Likely Boost Overall Inflation in Coming Months'

Comparaison

Variation de prix

AmerisourceBergen Corporation prévision

Objectif de Prix

By TipRanks

32.75% hausse

Prévisions sur 12 Mois

Moyen 411.44 USD  32.75%

Haut 440 USD

Bas 380 USD

Basé sur 10 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

10 ratings

9

Achat

1

Maintien

0

Vente

Sentiment

By Acuity

5 / 349Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Moyen

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos AmerisourceBergen Corporation

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat